首页> 外国专利> A drug delivery composition for controlled release of an active ingredient in the Environment for a period of tiempoprolongado stomach,A Pharmaceutical composition that comprises the use of said composition for the manufacture of a Medicament, a process for the Preparation

A drug delivery composition for controlled release of an active ingredient in the Environment for a period of tiempoprolongado stomach,A Pharmaceutical composition that comprises the use of said composition for the manufacture of a Medicament, a process for the Preparation

机译:一种用于控制环境中的活性成分释放铁皮龙胃一段时间的药物递送组合物,药物组合物,其包括所述组合物在制备药物中的用途,其制备方法

摘要

A drug supplied ingredient that controls the release of active ingredients for a long time in the stomach environment, including a microsystem containing a therapeutic agent (active air or drug) in its internal core,A layer of insoluble polymer water, such as ethyl cellulose for speed control, and the shell of a biological adhesive, in the form of a cationic polymer, especially diethylene glycol. The current drug supply system provides an important period of time for the retention of active ingredients in human fasting, a large number of water-soluble and fat soluble drugs, and the controlled release of talesdogs in a period of time related to demand Chemistry. These drugs include an H2 antagonist.A Gemini effective drug in the treatment of Helicobacter pylori. Heptabromodiphenyl ether is a process for preparing such a micro system, which includes drying the oil emulsifier in water or water, including ingredients. The retention time of the microloop obtained by this method in the stomach is much longer than that obtained by the aspersion conv drying method.Encyclopedia: the current invention of a drug supply component to control the release of an active ingredient that can be excluded in a chemical formulation, in an appropriate way of oral management, and can contain an effective active ingredient in the treatment of Spirulina pylori. H. A part of pylori's processing method (Kit) is also an object of present invention.
机译:药物提供的成分,可在胃环境中长时间控制活性成分的释放,包括在其内核中包含治疗剂(活性空气或药物)的微系统,一层不溶的聚合物水,例如乙基纤维素速度控制,以及阳离子聚合物(尤其是二甘醇)形式的生物粘合剂的外壳。当前的药物供应系统为在人类禁食中保留有效成分,大量的水溶性和脂溶性药物以及在与需求化学有关的一段时间内控释塔格犬提供了重要的时间。这些药物包括H2拮抗剂。这是一种用于治疗幽门螺杆菌的双子座有效药物。七溴二苯醚是制备这种微系统的方法,该方法包括在水或包含成分的水中干燥油乳化剂。通过这种方法获得的微环在胃中的保留时间要比通过喷雾干燥法获得的微环的保留时间长得多。化学制剂,以适当的口服方式治疗,并可以包含有效的活性成分治疗螺旋藻。 H.幽门螺旋杆菌的加工方法(试剂盒)的一部分也是本发明的目的。

著录项

  • 公开/公告号AR012854A1

    专利类型

  • 公开/公告日2000-11-22

    原文格式PDF

  • 申请/专利权人 WEST CHRISTOPHER;

    申请/专利号AR1998P102381

  • 发明设计人

    申请日1998-05-22

  • 分类号A61K9/22;A61K9/30;A61K9/36;A61K9/38;A61K31/16;A61K47/00;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号